Event
IDDST 2025

đź“… Date: May 12-14, 2025Â
📍 Location: Kobe, Japan
Meet Axxam in Kobe!
Bringing european discovery excellence to Asia-Pacific at the IDDST 2025
Axxam is proud to participate in the 21st Annual Congress of International Drug Discovery Science & Technology (IDDST-2025), taking place in Kobe, Japan, from May 12–14, 2025.
This global congress brings together thought leaders, scientists, and innovators working across therapeutic areas and disciplines. From AI-driven screening to cutting-edge target validation, IDDST is a hub for exchanging ideas and fostering international collaboration.
As a discovery-focused CRO headquartered in Europe, Axxam is excited to contribute to this global conversation with our unique blend of scientific depth and flexible partnering models.
Join us for our scientific presentation
As part of the IDDST 2025 program, our colleague Jeff will deliver a talk titled:
“Unlocking the Mystery of TMEM175: The Right Tools for the Right Purpose”
🗓️ May 13, 2025
🧬 Session: IDDST 05 – New Biotherapy Discovery
🕓 Time: 16:20–16:45
Don’t miss this opportunity to explore how the right technologies and expertise can drive success in tackling complex drug discovery targets like TMEM175.
What we offer to the scientific and biotech ecosystem
Axxam’s discovery platforms are designed for real-world complexity. Our teams work at the interface of biology, chemistry, and technology — supporting drug discovery projects with:
Advanced high-throughput and high-content screening
Custom cell-based and cell-free assays for challenging target classes
Organellar electrophysiology expertise
iPSC platform
Whether you’re an academic group, a biotech startup, or a global pharma company, we can help you move from question to discovery with speed and scientific rigor.
Let’s collaborate at IDDST 2025!
If you’re attending IDDST 2025, we’d love to meet and hear about your work. Whether you’re looking for a CRO partner or just want to exchange perspectives on innovation in drug discovery — our door is open.
👉 Book a meeting today and let’s start a conversation.


